Scott L. Pomeroy, MD, PhD
Neurologist-in-Chief; Chairman, Department of Neurology, Children’s Hospital Boston
Bronson Crothers Professor of Neurology, Harvard Medical School
• Clinical/Translational Neuroscience
Overview: Dr. Pomeroy uses molecular biology to determine how embryonal brain tumors are likely to respond to chemotherapy. He has developed a genetic method of determining which patients with medulloblastoma are most likely to benefit from therapy.